Food manufactures have been doing that since the 1800’s, heavily so since WWII. Never mind us, our parents grew up on processed foods.
Yeah okay. So have none of those “medical error” deaths got for care and see how many die. Please post the link to that stat…
According to a number of conservatives who post to this board the extent of medical error is a myth created by greedy attorneys specializing in medical malpractices and have become wealthy ripping off doctors by filing frivolous lawsuits.
generic glp 1 approved. daily but if it costs 2% of the weekly, who cares. hopefully they get their limited approval expanded to include other issues related to obesity this is where the fda could make a difference, generic drug approvals and quit extending patents FDA Announcement: The First Generic GLP-1 Shot Has Just Been Approved Many diabetes patients have experienced lowered drug costs in recent years, thanks to policies that have capped the price of diabetes prescriptions. For patients who have been paying for Ozempic or other glucagon-like peptide-1 medications, there may be another beneficial development: On December 23, the U.S. Food and Drug Administration (FDA) announced that they’ve cleared the first generic GLP-1 injectable “to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes as an adjunct to diet and exercise.” This language likely means that the drug will be available only to diabetics, in contrast to some of the name-brand medications in this class which have been approved for some weight loss cases. The drug is known generically as liraglutide, which the FDA says has been in short supply “with certain other GLP-1 medications.” This references the consistent shortages for drugs like semaglutides, known by brand names such as Ozempic and Wegovy, and tirzepatides, with brand names like Zepbound and Mounjaro. (In 2024 research published in the Journal of the American Medical Association, participants who took tirzepatide for weight loss generally saw greater benefit from tirzepatide, compared to semaglutide.)
Medical errors aren’t a myth. Just like many lawsuits are brought where there is no malpractice. It’s not either/or all or nothing.
Links plural … and as pan-panic turned hospitals and nursing homes into killing fields, healthcare may have been the leading cause of death 2020ff … Johns Hopkins study suggests medical errors are third-leading cause of death in U.S. Equal time to critics of study (have thoughts on this) … ‘Medical errors are the third leading cause of death’ and other statistics you should question Expanding the debate, this takes into account deaths accruing from standards of care … https://www.orthomolecular.org/library/jom/2005/pdf/2005-v20n01-p021.pdf
Lilly seeking to join lawsuit over compounded GLP-1 drugs Eli Lilly (NYSE:LLY) is reportedly seeking to oppose a lawsuit filed by compounding pharmacies over the FDA's determination that weight-loss and diabetes drugs such as Lilly's (NYSE:LLY) tirzepatide are no longer in short supply. Lilly (LLY) filed a motion to join the litigation on Wednesday, arguing that it could not rely on the FDA to defend its interests in the case, according to Reuters.
While that's accurate in the overwhelming majority of medical malpractice cases there has been actual malpractice. To discourage frivolous cases insurance companies are much less likely to settle than they were 20 or more years ago and it's not exactly cheap to pursue a medical malpractice lawsuit considering that expert testimony is absolutely essential and experts (well-credentialed doctors) can command rather high fees to testify on behalf of plaintiffs.
Makary’s own McQuacky study. https://emcrit.org/wp-content/uploa...spital-Deaths-in-America-Gianoli-and-Dunn.pdf Makary def pied piper of the emotionally frail.
Newest drug coming to market Retatrutide Video is a quick explanation from a Dr on how it works Dr. Jason Pencek on Instagram: "I am extremely excited about retatrutide. Retatrutide is a triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors, offering significant benefits for weight loss, blood sugar control, and reducing inflammation. It suppresses appetite, slows gastric emptying, and enhances fat burn, enabling weight loss of up to 24% of body weight in clinical trials. Retatrutide improves insulin secretion, lowers fasting glucose, and reduces HbA1c levels, making it highly effective for type 2 diabetes. Its anti-inflammatory effects reduce markers like CRP, capsase 1, NLRP3 and TNF-alpha. By addressing multiple pathways, Retatrutide provides a comprehensive approach to improving metabolic health and reducing risks of cardiovascular disease. It can be super helpful for the weight loss as well as the inflammation reduction that occurs when using it. #retatrutide #tirzepatide #semaglutide #glucagon #gip #glp1 #moreweightloss #tripleagonist #betterglucosecontrol #nlrp3 #TNFa #antiinflammatory #diabetes #obesity #longevity #chicago #antiagingmedicine #antiagingpeptides"
I think we know why you regard Makary as a quack, but I’ll address the doctors’ critiques you posted starting with … Note that the definition in the BMJ article (as well as in the several other referenced studies looking at medical “errors”) includes actions that are correct and not negligent, but do not result in successful outcomes. Consequently, any clinical outcome that is less than was desired can be considered a “medical error” in this distorted and outcome-biased view. Obviously these doctors believe Makary is being unfair. I don’t. Which is why I posted the pdf that characterizes healthcare as the leading cause of death when standards of care are considered. Am I going past Makary on this ? Sue me. Ex: if ventilators are killing patients, it matters not one wit that they were considered the proper course of treatment and administered as recommended per protocol. Error, not cough and kill Grandma, was responsible for 800,000 excess deaths in 2020-21.
The first two links clearly call into question how those “numbers” are derived. Here’s a little synopsis about the third “source”… “The Journal of Orthomolecular Medicine is not indexed by MEDLINE, a database of biomedical literature. Journals are selected for MEDLINE by the National Library of Medicine based on scope and coverage, quality of content, quality of editorial work, intended audience, quality of the layout, printing, graphics, and illustrations.[6] The journal is classified as a "Non-recommended Periodical" by the alternative medicine watchdog website, Quackwatch.org.” Even the alternative medicine groups think that “journal” is a joke. In one of the links they discussed better studies looking at the issue and found about 1% rate for medical errors causing death. That’s 1/10 the rate used to extrapolate the number you come up with. Curious what the death rate is from patients not following physicians directions….
